← Leaderboards
Wenbo Li
University Of Texas Hlth Sci Ctr Houston
$9,397,752
Attributed
$10,964,408
Total exposure
7
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.8M · FY2017–25$5M$3.8M$2.5M$1.3M$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,964,408 · 7
By mechanism
R01$6,909,063 · 4
U01$3,135,134 · 1
K22$486,042 · 1
R21$434,169 · 1
Top collaborators
- Krishna Pl Bhat3 shared
- Pavlos Msaouel2 shared
- Liuqing Yang2 shared
Most similar at University Of Texas Hlth Sci Ctr Houston
Same institution · by research overlap
- Phillip B Carpenter$1,976,446
Others in their field
Other Emerging Leaders on “Alzheimer&Apos”
- Lance Allen Johnson · University Of Kentucky$7,508,882
- Hyacinth Idu Hyacinth · University Of Cincinnati$6,781,590
- Yi Su · Weill Medical Coll Of Cornell Univ$6,486,733
- Julia Tcw · Icahn School Of Medicine At Mount Sinai$6,079,215
- Jessica Brooke Langbaum · Banner Health$6,050,741
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,936,362
Research focus
Alzheimer&AposCellsGenetic Transcription3-DimensionalArchitectureGenomeMolecularEnhancersPlayGenesInsightMediatingProteinsProgramsChip-SeqMalignant NeoplasmsChromatinGene ExpressionPathologicHuman DiseaseRegulationGene Expression RegulationCell NucleusComplex
Grant awards (24)
Enhancer RNAs in brain gene regulation and Alzheimer's disease$721,789
R01 · FY2025 · AG · contact PI
Elucidating T Cell Ferroptosis in Renal Medullary Carcinoma: 3D Genome Architecture Rewiring and Therapeutic Alleviation$671,046
R01 · FY2025 · CA
Novel Roles of TAZ and YAP in DNA Damage Repair with 3D Genome Organization and the Therapeutic Resistance in Glioblastoma$439,965
R01 · FY2025 · NS
Enhancer RNAs in brain gene regulation and Alzheimer's disease$739,201
R01 · FY2024 · AG · contact PI
Elucidating T Cell Ferroptosis in Renal Medullary Carcinoma: 3D Genome Architecture Rewiring and Therapeutic Alleviation$686,919
R01 · FY2024 · CA
Beyond Gene Dosage: Understanding Down Syndrome via 4D Genome Organization$624,204
U01 · FY2024 · HL · contact PI
Novel Roles of TAZ and YAP in DNA Damage Repair with 3D Genome Organization and the Therapeutic Resistance in Glioblastoma$427,263
R01 · FY2024 · NS
Mechanisms Underlying Enhancer Rnp Mediated Gene Regulation And Genome Organization$357,741
R01 · FY2024 · GM · contact PI
Enhancer RNAs in brain gene regulation and Alzheimer's disease$783,820
R01 · FY2023 · AG · contact PI
Beyond Gene Dosage: Understanding Down Syndrome via 4D Genome Organization$624,204
U01 · FY2023 · HL · contact PI
Novel Roles of TAZ and YAP in DNA Damage Repair with 3D Genome Organization and the Therapeutic Resistance in Glioblastoma$455,465
R01 · FY2023 · NS
Mechanisms Underlying Enhancer Rnp Mediated Gene Regulation And Genome Organization$357,741
R01 · FY2023 · GM · contact PI
Beyond Gene Dosage: Understanding Down Syndrome via 4D Genome Organization$624,204
U01 · FY2022 · HL · contact PI
Mechanisms Underlying Enhancer Rnp Mediated Gene Regulation And Genome Organization$357,741
R01 · FY2022 · GM · contact PI
Beyond Gene Dosage: Understanding Down Syndrome via 4D Genome Organization$624,204
U01 · FY2021 · HL · contact PI
Mechanisms Underlying Enhancer Rnp Mediated Gene Regulation And Genome Organization$357,741
R01 · FY2021 · GM · contact PI
Mechanisms Underlying Enhancer Rnp Mediated Gene Regulation And Genome Organization$194,890
R01 · FY2021 · GM · contact PI
Beyond Gene Dosage: Understanding Down Syndrome via 4D Genome Organization$638,318
U01 · FY2020 · HL · contact PI
Mechanisms Underlying Enhancer Rnp Mediated Gene Regulation And Genome Organization$357,741
R01 · FY2020 · GM · contact PI
Optogenetic Engineering of 3D Chromatin Architecture$230,599
R21 · FY2020 · GM · contact PI
Optogenetic Engineering of 3D Chromatin Architecture$203,570
R21 · FY2019 · GM · contact PI
Condensin-mediated enhancer and chromatin architectural control of breast cancer gene transcription$162,014
K22 · FY2019 · CA · contact PI
Condensin-mediated enhancer and chromatin architectural control of breast cancer gene transcription$162,014
K22 · FY2018 · CA · contact PI
Condensin-mediated enhancer and chromatin architectural control of breast cancer gene transcription$162,014
K22 · FY2017 · CA · contact PI